Aplasia cutis-myopia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1117OMIM:601075Q84.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aplasia cutis-myopia syndrome is an extremely rare genetic condition characterized by the combination of aplasia cutis congenita (a congenital absence or defect of skin, typically on the scalp) and high-grade myopia (severe nearsightedness). This syndrome was described in a small number of families, where affected individuals presented with localized areas of missing skin at birth, most commonly on the scalp, along with significant refractive errors of the eyes. The condition primarily affects the integumentary system (skin) and the visual system. Aplasia cutis congenita manifests as well-demarcated areas where the skin failed to develop normally during fetal life. These lesions may appear as ulcers or may be covered by a thin membrane at birth, and they typically heal with scarring. The associated myopia in this syndrome tends to be of high degree and may be recognized in early childhood. The combination of these two features in a familial pattern distinguishes this syndrome from isolated aplasia cutis congenita or isolated myopia. Treatment is symptomatic and supportive. Skin defects are managed with wound care and, if needed, surgical intervention for larger lesions or cosmetic concerns. Myopia is corrected with glasses, contact lenses, or potentially refractive surgery in adulthood. Regular ophthalmologic follow-up is recommended to monitor for complications of high myopia, such as retinal detachment. Given the rarity of this condition, no specific targeted therapies exist.

Also known as:

Clinical phenotype terms— hover any for plain English:

Aplasia cutis congenitaHP:0001057Calvarial skull defectHP:0001362Congenital nystagmusHP:0006934High myopiaHP:0011003Abnormal nervous system morphologyHP:0012639
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Aplasia cutis-myopia syndrome.

View clinical trials →

No actively recruiting trials found for Aplasia cutis-myopia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Aplasia cutis-myopia syndrome community →

No specialists are currently listed for Aplasia cutis-myopia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aplasia cutis-myopia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aplasia cutis-myopia syndromeForum →

No community posts yet. Be the first to share your experience with Aplasia cutis-myopia syndrome.

Start the conversation →

Latest news about Aplasia cutis-myopia syndrome

No recent news articles for Aplasia cutis-myopia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aplasia cutis-myopia syndrome

What is Aplasia cutis-myopia syndrome?

Aplasia cutis-myopia syndrome is an extremely rare genetic condition characterized by the combination of aplasia cutis congenita (a congenital absence or defect of skin, typically on the scalp) and high-grade myopia (severe nearsightedness). This syndrome was described in a small number of families, where affected individuals presented with localized areas of missing skin at birth, most commonly on the scalp, along with significant refractive errors of the eyes. The condition primarily affects the integumentary system (skin) and the visual system. Aplasia cutis congenita manifests as well-dem

How is Aplasia cutis-myopia syndrome inherited?

Aplasia cutis-myopia syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Aplasia cutis-myopia syndrome typically begin?

Typical onset of Aplasia cutis-myopia syndrome is neonatal. Age of onset can vary across affected individuals.